Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1121896

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Allergies: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of the availability of adrenaline auto-injectors.
	tabling member constituency	Lewisham, Deptford
	tabling member printed	Vicky Foxcroft
	uin	245895
	answer	answer is ministerial correction date of answer 30/04/2019 answer text <p>Supplies of EpiPen and other adrenaline auto-injectors are currently available in volumes that are sufficient to meet normal levels of demand. The Department continues to work very closely with all the manufacturers of adrenaline auto-injectors and can confirm that the supply situation continues to improve with further deliveries expected over the coming months. All patients who require an adrenaline auto-injector should now be able to obtain a device from their pharmacy.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 245896 question first answered 30/04/2019 13:08:53 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4491 label Biography information for Vicky Foxcroft

1121898

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Allergies: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that users are protected in the event that they are unable to have their prescriptions for adrenaline auto-injectors fulfilled by pharmacists.
	tabling member constituency	Lewisham, Deptford
	tabling member printed	Vicky Foxcroft
	uin	245896
	answer	answer is ministerial correction date of answer 30/04/2019 answer text <p>Supplies of EpiPen and other adrenaline auto-injectors are currently available in volumes that are sufficient to meet normal levels of demand. The Department continues to work very closely with all the manufacturers of adrenaline auto-injectors and can confirm that the supply situation continues to improve with further deliveries expected over the coming months. All patients who require an adrenaline auto-injector should now be able to obtain a device from their pharmacy.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 245895 question first answered 30/04/2019 13:08:53 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4491 label Biography information for Vicky Foxcroft

1122137

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the annual cost is of administering NHS prescription charges.
	tabling member constituency	Knowsley
	tabling member printed	Mr George Howarth
	uin	245660
	answer	answer is ministerial correction date of answer 30/04/2019 answer text <p>The annual cost to the NHS Business Services Authority of administering National Health Service prescription charges is around £75,000 per year. This figure covers the work of NHS Prescription Services, which includes the reimbursement and remuneration of dispensing contractors in England on behalf of the Department and NHS England. It does not include the work of the NHS Business Services Authority’s ‘Loss Recovery Service’ which involves checking prescription form exemption declarations, issuing Penalty Charge Notices and managing associated customer contact.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 30/04/2019 13:20:25 answering member 4455 label Biography information for Seema Kennedy
	tabling member	481 label Biography information for Sir George Howarth

1121894

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Skin Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much the NHS has spent on providing skin cancer treatment in each of the last five years.
	tabling member constituency	Rhondda
	tabling member printed	Chris Bryant
	uin	245692
	answer	answer is ministerial correction date of answer 30/04/2019 answer text <p>The requested information is not collected centrally.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 30/04/2019 12:26:25 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1446 label Biography information for Sir Chris Bryant

1122003

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Commonwealth: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has made to prepare for the upcoming Commonwealth Health Ministers meeting.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	245725
	answer	answer is ministerial correction date of answer 30/04/2019 answer text <p>The Department of Health and Social Care will be sending a delegation to represent the United Kingdom at the Commonwealth Health Ministers’ Meeting. As in previous years the Department of Health and Social Care is working with the Department for International Development and the Foreign and Commonwealth Office on our preparations for the wide ranging agenda items, which this year come under the theme of ‘Universal Health Coverage: Reaching the unreached, ensuring no one is left behind’. This will include preparing cross-Government views on the papers for discussion at the meeting, and examples of UK practices we might want to share. We will also be encouraging follow up on the health commitments made at the Commonwealth Summit in London last year.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 30/04/2019 13:50:26 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1538 label Biography information for Rosie Cooper

1121969

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: East Sussex
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to reduce waiting times for NHS hospital appointments for cancer patients in (a) East Sussex and (b) Brighton and Hove.
	tabling member constituency	Hove
	tabling member printed	Peter Kyle
	uin	245901
	answer	answer is ministerial correction date of answer 25/04/2019 answer text <p>Brighton and Sussex University Hospitals NHS Trust has taken several steps to reduce waiting times for cancer patients and as a result there has been a 40% reduction in the number of patients waiting greater than 104 days since January 2019, and an overall reduction in the size of the cancer waiting list. Additional funds have been secured from the Cancer Alliance, and improvement plans are in place at tumour site level.</p><p>In addition, to improve elective waiting times more broadly, local clinical commissioning groups have commissioned significantly more elective activity this year than was delivered last year to improve Referral to Treatment performance, and there is a focus on reducing the number of cancelled operations at the Trust. Additional capacity has also been secured to support a reduction in diagnostic waiting times.</p><p>Reducing waiting times continues to be a high priority for the National Health Service. Nationally, the NHS Long Term Plan sets out the NHS priorities going forward and reiterates the focus to increase the amount of planned surgery year-on-year, to cut long waits, and reduce the size of hospital waiting lists.</p><p>The Clinical Standards Review is all part of delivering the clear commitments set out in the NHS Long Term Plan to improve urgent and emergency care performance and reduce provider waiting lists over the next five years, as well as delivering the new ambitions set out, all within the final long-term funding settlement. The clinically-led review of standards is considering the appropriateness of operational standards for physical and mental health relating to planned, unplanned urgent or emergency care, as well as cancer.</p><p>Furthermore, we have committed to introducing a new 28-day faster diagnosis standard from next year so that patients are able to start treatment as quickly as possible. The new standard will see patients who are referred for investigation with suspected cancer receive a diagnosis or have cancer ruled out within 28 days. Trusts will be performance managed from April 2020.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 25/04/2019 15:05:50 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4505 label Biography information for Peter Kyle

1122195

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Parkinson's Disease: Health Education
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase public understanding of Parkinson's disease.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	245682
	answer	answer is ministerial correction date of answer 30/04/2019 answer text <p>The National Health Service website provides information for patients and the public on a wide range of conditions, including Parkinson’s disease. The website provides information on causes, symptoms, diagnosis, treatment and further information on living with Parkinson’s.</p><p>The National Institute for Health and Care Excellence published guidance on ‘Parkinson’s disease in adults’ in July 2017. This provides recommendations and guidance for healthcare professionals, commissioners as well as adults with Parkinson’s diseases and their families and carers.</p><p>This information and guidance can be found via the following links:</p><p><a href="http://www.nhs.uk/conditions/parkinsons-disease/" target="_blank">www.nhs.uk/conditions/parkinsons-disease/</a></p><p><a href="http://www.nice.org.uk/guidance/ng71" target="_blank">www.nice.org.uk/guidance/ng71</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 30/04/2019 13:12:03 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1436 label Biography information for Paul Farrelly

1122082

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the answer of 1 April 2019 to Question 237706 on Epilepsy: Drugs, and with reference to the publication entitled, Epilepsy Society Calls For Urgent Review Of Medicines Supply Chain, published by the Epilepsy Society on 8 April 2019, if he will make an assessment of trends in the level of people with epilepsy that are unable to obtain epilepsy medication.
	tabling member constituency	Glasgow North
	tabling member printed	Patrick Grady
	uin	245842
	answer	answer is ministerial correction date of answer 25/04/2019 answer text <p>The Department fully understands that maintaining access to epilepsy medications is vitally important to many people in this country.</p><p>The production of medicines is complex and must meet rigorous quality and safety standards. Disruption to the medicines supply chain is rare, but can occur due to manufacturing issues, supply of raw materials or batch failures.</p><p>The Department has well established processes to monitor the medicines supply chain, and to manage and mitigate the small number of supply problems that may arise at any one time. In addition, from January this year, it became a legal requirement for pharmaceutical companies to report this information to us in a timely manner. The new requirements aim to address the ongoing concerns about medicine supply issues and to ensure that the Department has relevant information at the earliest point possible to help manage supply shortages and mitigate any potential impacts on patients.</p><p>The Department responded to concerns over medicines used in epilepsy by seeking specialist advice to develop a clinical management plan. The clinical management plan aims to ensure treatment for affected patients can be managed appropriately in the unlikely event of any disruption to supply. We communicated information about the supply issue and clinical management plan to the National Health Service and affected patients via patient groups.</p><p>We continue to work closely with industry and partners in the health system to help prevent shortages and to ensure that the risks to patients are minimised when supply issues do arise.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 245843 question first answered 25/04/2019 14:14:30 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4432 label Biography information for Patrick Grady

1122083

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will respond to the request from the Epilepsy Society for an urgent review of the medicines supply chain.
	tabling member constituency	Glasgow North
	tabling member printed	Patrick Grady
	uin	245843
	answer	answer is ministerial correction date of answer 25/04/2019 answer text <p>The Department fully understands that maintaining access to epilepsy medications is vitally important to many people in this country.</p><p>The production of medicines is complex and must meet rigorous quality and safety standards. Disruption to the medicines supply chain is rare, but can occur due to manufacturing issues, supply of raw materials or batch failures.</p><p>The Department has well established processes to monitor the medicines supply chain, and to manage and mitigate the small number of supply problems that may arise at any one time. In addition, from January this year, it became a legal requirement for pharmaceutical companies to report this information to us in a timely manner. The new requirements aim to address the ongoing concerns about medicine supply issues and to ensure that the Department has relevant information at the earliest point possible to help manage supply shortages and mitigate any potential impacts on patients.</p><p>The Department responded to concerns over medicines used in epilepsy by seeking specialist advice to develop a clinical management plan. The clinical management plan aims to ensure treatment for affected patients can be managed appropriately in the unlikely event of any disruption to supply. We communicated information about the supply issue and clinical management plan to the National Health Service and affected patients via patient groups.</p><p>We continue to work closely with industry and partners in the health system to help prevent shortages and to ensure that the risks to patients are minimised when supply issues do arise.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 245842 question first answered 25/04/2019 14:14:30 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4432 label Biography information for Patrick Grady

1121812

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liver Diseases: Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the level of fatty liver disease among young people.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	245601
	answer	answer is ministerial correction date of answer 25/04/2019 answer text <p>The following table from NHS Digital shows a count of finished admission episodes (FAEs) with a primary diagnosis of K76.0 - Fatty (Change of) liver, for patients aged under 18, for the financial years 2013-14 to 2017-18. Clinical code K76.0 includes, but is not limited to, non-alcoholic fatty liver disease.</p><p>Activity in English National Health Service hospitals and English NHS-commissioned activity in the independent sector</p><table><tbody><tr><td><p>Year</p></td><td><p>FAEs</p></td></tr><tr><td><p>2013-14</p></td><td><p>96</p></td></tr><tr><td><p>2014-15</p></td><td><p>115</p></td></tr><tr><td><p>2015-16</p></td><td><p>185</p></td></tr><tr><td><p>2016-17</p></td><td><p>157</p></td></tr><tr><td><p>2017-18</p></td><td><p>195</p></td></tr></tbody></table><p>Source: Hospital Episode Statistics (HES), NHS Digital</p><p>An FAE is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period. Changes to the figures over time need to be interpreted in the context of improvements in data quality and coverage, improvements in coverage of independent sector activity and changes in NHS practice. For example, apparent reductions in activity may be due to a number of procedures that may now be undertaken in outpatient settings and so are no longer included in admitted patient HES data. Conversely, apparent increases in activity may be due to improved recording of diagnosis or procedure information.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 25/04/2019 14:02:17 answering member 4455 label Biography information for Seema Kennedy
	tabling member	308 label Biography information for Mr Jim Cunningham